Appendicitis Acute
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
GH
1 program
Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CTN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
GE HealthCareWeight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT
Clinical Trials (1)
Total enrollment: 292 patients across 1 trials
NCT05878665GE HealthCareWeight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT
Low-dose Contrast Media for Low-kVp Abdomen CT
Start: Dec 2023Est. completion: Dec 2025292 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 292 patients
1 companies competing in this space